Skip to main content
. 2023 Jun 19;19(3):222–231. doi: 10.4244/EIJ-D-22-00919

Central illustration. Clinical performance of the novel ultrathin sirolimus-eluting iron bioresorbable scaffold.

Central illustration

The iron bioresorbable scaffold (A), a representative case with angiographic and OCT follow-up at 1 and 3 years (B), and selected study results from the first-in-human experience in its implant in 45 patients with a single non-complex coronary artery lesion (C). IVUS: intravascular ultrasound; OCT: optical coherence tomography; QCA: quantitative coronary angiography